A 48-year-old man with 18 years of type 1 diabetes and HbA1c 9.8% presents for annual retinal screening. Visual acuity is 6/9 OU. Fundoscopy reveals abundant dot-blot hemorrhages and microaneurysms in all four quadrants, multiple cotton-wool spots, and the structure marked **A** (venous beading and IRMA) is prominently visible in the supero-temporal and infero-temporal arcades. There is no neovascularization at the disc or elsewhere. Based on the ETDRS 4-2-1 rule, what is the most appropriate next step in management?
A. Initiate pan-retinal photocoagulation (PRP) or intravitreal anti-VEGF therapy, with aggressive systemic control and close follow-up every 2–4 months
B. Reassure the patient and repeat screening in 12 months with tight glycemic control alone
C. Refer for cataract surgery to improve visual acuity before commencing any retinal intervention
D. Perform immediate vitrectomy for impending vitreous hemorrhage
Explanation
Why option 2 is correct
The presence of venous beading (marked A) in two quadrants, combined with intraretinal hemorrhages in four quadrants, satisfies the ETDRS 4-2-1 rule for severe non-proliferative diabetic retinopathy (SEVERE NPDR). Venous beading is the single most predictive feature of progression to proliferative DR. Severe NPDR progresses to PDR in 15% at 1 year and 45–50% at 5 years. The standard of care is aggressive systemic control (glycemia, blood pressure, lipids) combined with early pan-retinal photocoagulation (PRP) or intravitreal anti-VEGF therapy (Protocol S, CLARITY trials), with tight follow-up every 2–4 months. PRP or anti-VEGF is particularly indicated in patients with poor compliance, monocular vision, or planned cataract surgery—this patient's HbA1c of 9.8% suggests suboptimal control and high progression risk.
Why each distractor is wrong
Option 1 (reassurance and 12-month follow-up): Severe NPDR with venous beading carries a 15% risk of progression to PDR within 1 year. Delaying intervention to 12 months is inappropriate; the standard is close follow-up every 2–4 months with concurrent PRP or anti-VEGF. Glycemic control alone is insufficient.
Option 3 (immediate vitrectomy): Vitrectomy is reserved for established proliferative DR with vitreous hemorrhage or tractional retinal detachment. This patient has no NVD, NVE, or vitreous hemorrhage—vitrectomy is not indicated.
Option 4 (cataract surgery first): While cataract surgery is a relative indication for early PRP (to prevent post-operative neovascularization), the patient's visual acuity is 6/9 OU—not significantly reduced by cataract. Retinal intervention should not be deferred for elective cataract surgery in this setting.
High-YieldNEET PG
ETDRS 4-2-1 rule: Severe NPDR = intraretinal hemorrhages in 4 quadrants OR venous beading in 2 quadrants OR IRMA in 1 quadrant—any ONE criterion suffices. Venous beading is the most predictive of progression; manage with PRP/anti-VEGF + tight systemic control + 2–4 monthly review.
ETDRS Report 12; AAO BCSC Retina
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
